The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Weight loss products (4)
- Advertising (115)
- Regulatory compliance (79)
- Prescription medicines (75)
- COVID-19 (70)
- Therapeutic goods regulation (60)
- Listed medicines (48)
- Non-prescription medicines (47)
- Legislation (46)
- COVID-19 vaccines (36)
- Complementary medicines (28)
- Manufacturing (27)
- Medicine safety (27)
- Vaping hub (26)
- Assessed listed medicines (25)
- Australian Register of Therapeutic Goods (ARTG) (16)
- Labelling and packaging (16)
- Compliance and enforcement hub (15)
- Over the counter (OTC) medicines (15)
- Medicinal cannabis hub (13)
- Scheduling (national classification system) (12)
- Import and export (11)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Safety (10)
- Medical devices safety (9)
- Alert/Advisory (8)
- Advisory bodies and committees (4)
- Shortages (4)
- Clinical trials (3)
- Sunscreens (3)
- Advanced therapies (1)
- Biological medicines (1)
- Blood and blood components (1)
- Cosmetics (1)
- Fees and payments (1)
- Prescription opioids hub (1)
- Registered complementary medicines (1)
Search
4 result(s) found, displaying 1 to 4
-
Compliance undertakingsWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Media releasesWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Media releasesAmendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6) have been made resulting in compounded GLP-1 RA products no longer being able to be compounded by pharmacists and supplied to patients.
-
NewsSupplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time.